150 related articles for article (PubMed ID: 23645700)
1. Hyperphosphatemic tumoral calcinosis.
Mallick S; Ahmad Z; Gupta AK; Mathur SR
BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645700
[TBL] [Abstract][Full Text] [Related]
2. Nonfamilial hyperphosphatemic tumoral calcinosis with ulnar neuropathy.
Shetty GM; Murari AS; Shah SV; Dhengle S
Joint Bone Spine; 2009 Mar; 76(2):198-201. PubMed ID: 19073370
[TBL] [Abstract][Full Text] [Related]
3. Recurrent primary hyperphosphatemic tumoral calcinosis: a case report.
Rangaswamy M; Jayashree K; Saggam P; Vimala MG
Acta Cytol; 2010; 54(5 Suppl):1003-6. PubMed ID: 21053587
[TBL] [Abstract][Full Text] [Related]
4. Tumoral calcinosis with hyperphosphatemia.
Mahadevan S; Adhisivam B; Kumar CN
Indian J Pediatr; 2005 Oct; 72(10):889-90. PubMed ID: 16272668
[TBL] [Abstract][Full Text] [Related]
5. Recurrent hyperphosphatemic tumoural calcinosis.
Amit S; Agarwal A; Nigam A; Rao YK
BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 23010461
[TBL] [Abstract][Full Text] [Related]
6. Hyperphosphatemic tumoral calcinosis: a 10-year follow-up.
Alves C; Lima R
J Pediatr Endocrinol Metab; 2011; 24(1-2):25-7. PubMed ID: 21528811
[TBL] [Abstract][Full Text] [Related]
7. Complete resolution of tumoral calcinosis after renal transplantation.
Miyamoto M; Shibagaki Y; Kimura K
Urology; 2012 Jun; 79(6):e90-1. PubMed ID: 22516362
[TBL] [Abstract][Full Text] [Related]
8. Hyperphosphatemic tumoral calcinosis.
Savaci N; Avunduk MC; Tosun Z; Hoşnuter M
Plast Reconstr Surg; 2000 Jan; 105(1):162-5. PubMed ID: 10626985
[TBL] [Abstract][Full Text] [Related]
9. Childhood calcinosis cutis.
Rodríguez-Cano L; García-Patos V; Creus M; Bastida P; Ortega JJ; Castells A
Pediatr Dermatol; 1996; 13(2):114-7. PubMed ID: 9122066
[TBL] [Abstract][Full Text] [Related]
10. Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?
Claramunt-Taberner D; Bertholet-Thomas A; Carlier MC; Dijoud F; Chotel F; Silve C; Bacchetta J
Pediatr Nephrol; 2018 Jul; 33(7):1263-1267. PubMed ID: 29594503
[TBL] [Abstract][Full Text] [Related]
11. Primary hyperphosphatemic tumoral calcinosis: a case report.
Huang J; Cao LG; Zhang TR; Li SM; Meng QQ
Osteoporos Int; 2022 Jan; 33(1):309-312. PubMed ID: 34245344
[TBL] [Abstract][Full Text] [Related]
12. Hyperphosphatemic familial tumoral calcinosis mimicking a cystic hemo-lymphangioma on MRI.
Houss SE; LRhorfi N; Yousfi ZE; Haddad SE; Chat L; Allali N; Rguieg N; Lamalmi N
Radiol Case Rep; 2022 Dec; 17(12):4603-4607. PubMed ID: 36193273
[TBL] [Abstract][Full Text] [Related]
13. Recurrent tumoral calcinosis.
Nggada HA; Eni UE; Lawan MA; Pindiga UH; Na'aya HU; Khalil MI
Trop Doct; 2006 Oct; 36(4):240-1. PubMed ID: 17034706
[TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic analysis of idiopathic normophosphatemic tumoral calcinosis in 19 patients.
Zuo QY; Cao X; Liu BY; Yan D; Xin Z; Niu XH; Li C; Deng W; Dong ZY; Yang JK
J Endocrinol Invest; 2020 Feb; 43(2):173-183. PubMed ID: 31535357
[TBL] [Abstract][Full Text] [Related]
15. A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features.
Dumitrescu CE; Kelly MH; Khosravi A; Hart TC; Brahim J; White KE; Farrow EG; Nathan MH; Murphey MD; Collins MT
Osteoporos Int; 2009 Jul; 20(7):1273-8. PubMed ID: 18982401
[TBL] [Abstract][Full Text] [Related]
16. Tumoral calcinosis in a patient undergoing hemodialysis.
Suzuki K; Takahashi S; Perruchoud A; Tanaka Y; Sezai Y
Acta Orthop Scand; 1979 Feb; 50(1):27-31. PubMed ID: 425827
[TBL] [Abstract][Full Text] [Related]
17. Hyperphosphatemic Tumoral Calcinosis after Total Knee Arthroplasty.
Mochizuki T; Ikari K
Case Rep Orthop; 2017; 2017():1528201. PubMed ID: 29123932
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic sporadic tumoral calcinosis of the hip: successful oral bisphosphonate therapy.
Jacob JJ; Mathew K; Thomas N
Endocr Pract; 2007; 13(2):182-6. PubMed ID: 17490934
[TBL] [Abstract][Full Text] [Related]
19. A novel
Zuo Q; Yang W; Liu B; Yan D; Wang Z; Wang H; Deng W; Cao X; Yang J
Front Endocrinol (Lausanne); 2022; 13():1008800. PubMed ID: 36213261
[TBL] [Abstract][Full Text] [Related]
20. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer.
Lammoglia JJ; Mericq V
Horm Res; 2009; 71(3):178-84. PubMed ID: 19188744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
